AU2002252900A1 - Individualization of therapy with erectile dysfunction agents - Google Patents

Individualization of therapy with erectile dysfunction agents

Info

Publication number
AU2002252900A1
AU2002252900A1 AU2002252900A AU2002252900A AU2002252900A1 AU 2002252900 A1 AU2002252900 A1 AU 2002252900A1 AU 2002252900 A AU2002252900 A AU 2002252900A AU 2002252900 A AU2002252900 A AU 2002252900A AU 2002252900 A1 AU2002252900 A1 AU 2002252900A1
Authority
AU
Australia
Prior art keywords
individualization
therapy
erectile dysfunction
dysfunction agents
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002252900A
Inventor
Brian Leyland-Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU2002252900A1 publication Critical patent/AU2002252900A1/en
Abandoned legal-status Critical Current

Links

AU2002252900A 2001-04-26 2002-04-25 Individualization of therapy with erectile dysfunction agents Abandoned AU2002252900A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/286,336 2001-04-26

Publications (1)

Publication Number Publication Date
AU2002252900A1 true AU2002252900A1 (en) 2002-11-11

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002322719A1 (en) Delivery of therapeutic capable agents
IL157640A0 (en) Pyrazolopyrimidines as therapeutic agents
PL363740A1 (en) Pyrazolopyrimidines as therapeutic agents
GB0111872D0 (en) Therapeutic agents and methods
AU2001252135A1 (en) Therapeutic agents
AU2001274649A1 (en) Topical preparation of alprostadil for the treatment of erectile dysfunction
GB0113841D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
AU2002302223A1 (en) Individualization of therapy with analgesics
GB0113842D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
AU2002334891A1 (en) Tumor targeted photodiagnostic-phototherapeutic agents
GB0111191D0 (en) Therapeutic agents
AU2002246924A1 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
GB0113843D0 (en) Therapeutic agents
AU2002257411A1 (en) Individualization of therapy with antineoplastic agents
AU2002349225A1 (en) Individualization of therapy with antiviral agents
AU2002244575A1 (en) Individualization of therapy with antidepressants
AU2002257451A1 (en) Individualization of therapy with antibiotic agents
AU2002252900A1 (en) Individualization of therapy with erectile dysfunction agents
AU2002350344A1 (en) Individualization of therapy with antihistamines
GB0108982D0 (en) Therapeutic agents
AU2002249042A1 (en) Individualization of therapy with hyperlipidemia agents
AU2003231154A1 (en) Topical treatment of erectile dysfunction
AU2002333079A1 (en) Individualization of therapy with anxiolitics